(Hypertension. 2001;37:955.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk.
Correspondence to J.P.M. Wesselman, PhD, Department of Pharmacology and Toxicology, University Maastricht, PO Box 616, 6200 MD Maastricht, Netherlands. E-mail j.wesselman{at}farmaco.unimaas.nl
| Abstract |
|---|
|
|
|---|
Key Words: arteries remodeling pressure signal transduction proto-oncogene proteins c-fos src-family kinases protein kinases
| Introduction |
|---|
|
|
|---|
The hypothesis that pressure activates mechanisms that may eventually lead to arterial remodeling has been investigated in cultured vascular smooth muscle cells. Mechanical stimulation, such as the application of pressure, stretch, or deformation, of cultured arterial smooth muscle cells has been shown to induce a growth response.9 10 Furthermore, it was found that this type of stimulation induced the activation of the extracellular signalregulated kinase (ERK) and c-jun N-terminal kinase (JNK) mitogen-activated protein (MAP) kinase cascades11 12 13 14 ; expression of proto-oncogenes, such as c-fos, c-myc, and Egr-19 15 16 17 ; release of growth factors, such as platelet-derived growth factor (PDGF) A,10 insulin-like growth factor I,18 and fibroblast growth factor-219 ; expression of connexin 4316 ; and synthesis of smooth muscle myosin,20 collagen,21 and elastin.15 These results demonstrate that mechanical stimulation indeed activates mechanisms that promote remodeling or growth in these cells. However, several studies clearly show that the responses to mechanical stimulation are dependent on the plating medium and the specific adhesion molecules that are engaged.11 17 22 This suggests that the candidate signaling pathways, as found in cultured cells, should be confirmed in an actual intact artery with a natural cell phenotype and matrix.
Thus far, only a few studies that sought to determine the mechanisms by which pressure induces a growth or remodeling response have been performed on intact arteries. Xu et al23 demonstrated that acute hypertension activated ERK and JNK MAP kinases and increased expression of c-fos and c-jun proto-oncogenes and AP-1 binding activity in rat large arteries in vivo. In our group, work from Parker et al8 and Dobrian et al24 suggests that the aortic and femoral artery hypertrophy in angiotensin IIinduced and 1-kidney, 1 clip hypertensive rat is mediated by pressure-induced expression of PDGF-A. Furthermore, Adam et al25 showed that the application of mechanical load rapidly, within a minute, increased levels of ERK MAP kinase activity in isolated strips of porcine carotid artery. Birukov et al26 found that pressurization of cannulated rabbit aorta in organ culture activated ERK. In small arteries, which show a different remodeling response, pressure may activate other signal transduction mechanisms. We previously showed that elevating intraluminal pressure from 90 to 140 mm Hg in cannulated rat mesenteric small arteries increased the expression of c-fos and c-myc.27 28 Recently we showed that this response did not depend on intracellular calcium, protein kinase C, or intact actin filaments but was inhibited by genistein, a tyrosine kinase inhibitor.29
In the present study we sought to further characterize the mechanotransduction mechanism by which pressure induces proto-oncogene expression in intact small arteries. In particular, we tested, using specific inhibitors, whether pressure-induced c-fos expression in cannulated rat mesenteric small arteries required src-family tyrosine kinases. Src tyrosine kinases are associated with integrins at the focal adhesion sites. Here, the integrins connect the extracellular matrix with the intracellular cytoskeleton and may thus mediate mechanotransduction of the pressure stimulus.30 Second, we examined the role of ERK MAP kinases, which, like c-fos, have been associated with proliferative responses to mechanical stimulation.31
| Methods |
|---|
|
|
|---|
For the c-fos experiments, we followed a previously described protocol for altering pressure.27 28 29 During a 1-hour equilibration period, the intraluminal pressure was raised in small steps of 15 mm Hg, from 30 to 90 mm Hg, at 37°C. After equilibration, the intraluminal pressure in 1 artery was increased to 140 mm Hg in 1 step to simulate an acute hypertensive situation, while the other artery was maintained at 90 mm Hg, the physiological pressure.32 These pressures were maintained for 1 hour. Subsequently, the arteries were removed from the cannulas, and c-fos expression was determined by means of reverse transcriptasepolymerase chain reaction (RT-PCR). For the experiments in which ERK MAP kinase phosphorylation was analyzed, the arteries were equilibrated at 90 mm Hg for a period of 1 hour at 37°C. Subsequently, 1 of the 2 vessels was subjected to an intraluminal pressure of 140 mm Hg for 1, 5, or 10 minutes, while the other artery remained at 90 mm Hg. Then the arteries were removed from the cannulas, and ERK phosphorylation was analyzed by Western blotting.
Experiments were always performed in a paired fashion; the 2 arteries that were compared were taken from the same rat. To further reduce the variability of the c-fos experiments, 2 isolated arteries were obtained by cutting 1 vessel into 2 segments of similar axial length (2 to 3 mm). This was not possible for the experiments in which levels of ERK MAP kinase phosphorylation were determined because more tissue was needed for the assay. All inhibitors were administered extraluminally in the tissue bath during the 1-hour incubation period.
RNA Isolation and RT-PCR
Expression of c-fos was determined by RT-PCR. After
the pressure protocol, the arteries were quickly removed from the
cannulas and stored in RNAlater (Ambion). The vessels were carefully
ground in cold guanidinium isothiocyanate and 2-mercapto-ethanol with
the use of glass tissue grinders. RNA was isolated and purified on a
GlassMax RNA Microisolation Spin Cartridge System (GIBCO BRL). The
quantity (usually between 150 and 1000 ng per artery) and purity of the
RNA were determined by spectrophotometry using a Genequant device
(Pharmacia). The RT was performed with the use of a Reverse
Transcription System (Promega). Care was taken to perform the RT
reaction with the same quantity of RNA (
100 ng). One fourth of the
RT volume (5 µL cDNA template) was amplified with primers (GIBCO BRL)
for both c-fos and cyclophilin. Cyclophilin was used as the
housekeeping gene for semiquantitative analysis of c-fos
expression because it has been demonstrated to be abundantly expressed
in vascular smooth muscle and to be refractory to many stimuli,
including mechanical
loading.33 For the PCR, a
Taqbead Hot Start Polymerase (Promega) was used. The cDNA and 1.25 U of
Taq polymerase were added to 45
µL of master mix. The samples underwent 30 cycles of denaturation
(94°C), annealing (52°C), and extension (72°C). The PCR
product was electrophoresed on an 8% polyacrylamide gel.
The bands were visualized with the use of the EagleEye II Still Video
System (Stratagene) and quantified by means of SigmaGel software (SPSS
Inc). For amplification of c-fos cDNA, the sense primer was
5'-GAT-GTT-CTC-GGG-TTT-CAA-CGC-G-3', and the antisense primer was
5'-TGC-AGC-CAT-CTT-ATT-CCT-TTC-CC-3', which gave a 451-bp DNA
product. The c-fos primers were chosen such that they span 3
introns. The primer sequences for cyclophilin were sense:
5'-GTC-GCG-TCT-GCT-TCG-AGC-TGT-TTG-C, and antisense:
5'-CCA-TGG-CTT-CCA-CAA-TGC-TCA-TGC-C-3', which gave a DNA band of
375 bp.
Western Blotting
ERK 1/2 MAP kinase phosphorylation
was detected by Western blotting. After the pressure protocol, the
arteries were quickly removed from the cannulas and immediately ground
with glass tissue grinders in ice-cold buffer (50 µL) of the
following composition: Tris-HCl 50 mmol/L (pH 7.4), NP-40 1%,
Na-deoxycholate 0.25%, NaCl 150 mmol/L, EDTA 1 mmol/L,
phenylmethylsulfonyl fluoride 1 mmol/L, aprotinin 1
µg/mL, leupeptin 1 µg/mL, pepstatin 1 µg/mL,
Na3VO4 1 mmol/L, NaF
1 mmol/L (final concentrations). The protein concentration was
measured with the bicinchoninic acid protein assay. Equal amounts of
protein (
10 µg) were separated by electrophoresis on a 10%
polyacrylamide gel and electroblotted on a PVDF transfer
membrane blocked with Tris-buffered saline/Tween and NAP-Sureblocker
(Geno Technology). Blots were incubated with a
phosphorylation-specific primary antibody for ERK 1/2
MAP kinase (Santa Cruz Biochemicals), followed by a horseradish
peroxidaselabeled secondary antibody (Promega). Antibody complexes
were detected by enhanced chemiluminescence (Amersham Pharmacia
Biotech). Prestained rainbow markers (Amersham) were used as molecular
mass standards.
Chemicals
PP2 was obtained from Calbiochem-Novabiochem Corp,
PD98059 from New England BioLabs Inc, and herbimycin A and PP1 from
Biomol Research Laboratories, Inc. All other compounds were purchased
from Sigma Chemical Co.
Data Analysis
Results are presented as mean±SEM.
Statistical significance was tested by ANOVA followed by Bonferroni
multiple comparison test. The null hypothesis was rejected at
P<0.05, and n depicts the
number of rats.
| Results |
|---|
|
|
|---|
|
|
Effects of Inhibitors for Src
Tyrosine Kinase and the ERK Cascade on C-Fos Expression
To determine the involvement of src tyrosine kinases in
pressure-induced c-fos expression, we used the src
inhibitors herbimycin A (1 µmol/L, n=10), PP1 (10
µmol/L, n=10), and PP2 (10 µmol/L, n=10).
Figure 2 summarizes the results. Herbimycin A and PP1 did
not influence c-fos expression at 90 mm Hg but suppressed the
additional expression induced by pressure elevation; the
c-fos/cyclophilin ratios at 90 and 140 mm Hg were not
significantly different
(Figure 2A). Unexpectedly, in the presence of PP2 basal c-fos
levels appeared to be increased. However, like the other src
inhibitors, it also blocked the pressure-induced rise of
the c-fos/cyclophilin ratio. Thus, all the src tyrosine kinase
inhibitors blocked the increase of c-fos expression that
was induced by high pressure
(Figure 2B). The specific inhibitor of MAP
kinase/ERK kinase (MEK) PD98059 (30 µmol/L, n=10) was used to assess
the involvement of the ERK 1/2 MAP kinase pathway in pressure-induced
c-fos expression.
Figure 2 demonstrates that, although basal c-fos levels were
increased, high pressure did not influence the c-fos/cyclophilin
ratio.
Pressure-Induced ERK MAP Kinase
Phosphorylation
To further unravel the involvement of the ERK MAP
kinase pathway, we investigated whether high pressure induces
phosphorylation. By means of Western blotting, with a
phosphorylation-specific primary antibody for ERK 1/2,
we investigated whether exposure of cannulated mesenteric small
arteries to high pressure evokes ERK phosphorylation.
In 3 different sets of experiments, the arteries were subjected to high
pressure for 1, 5, and 10 minutes (3 pairs of arteries for each
period). One minute at 140 mm Hg changed ERK
phosphorylation to 119%, 1042%, and 27%, 5 minutes
at 140 mm Hg to 560%, 302%, and 166%
(Figure 3A), and 10 minutes at 140 mm Hg to 157%,
40%, and 62%. These results show that a 1-minute, as well as a
10-minute, exposure to high pressure did not uniformly change ERK
phosphorylation, whereas a 5-minute exposure to
140 mm Hg consistently increased ERK
phosphorylation in all 3 experiments
(Figure 3A). To investigate whether pressure-induced ERK
phosphorylation depends on src tyrosine kinases, we
tested whether PP1 (10 µmol/L, n=3) influenced the response to
5-minute exposure to 140 mm Hg.
Figure 3B shows that levels of ERK
phosphorylation were extremely low in 1 pair of
arteries, both under control conditions and after 5 minutes at 140
mm Hg. For the 2 other pairs that were treated with PP1,
phosphorylation was not detectable at either pressure
(data not shown). Collectively, the results show that blockers of src
tyrosine kinases and MEK inhibited pressure-dependent c-fos expression
and that src blockade suppressed ERK-phosphorylation as
well.
|
| Discussion |
|---|
|
|
|---|
Protein tyrosine kinases consist of several subclasses, and
some of those, eg, focal adhesion kinase or src, are associated with
integrins. Integrins are transmembrane adhesion molecules that couple
the extracellular matrix to the cytoskeleton at the focal adhesion
sites, and evidence is accumulating that integrins are involved in the
transduction of mechanical
stimuli.30 31
Results from several studies suggest that interactions between
integrins and specific matrix proteins may be critically important for
the transduction of mechanical stimulation, which eventually leads to a
mitogenic response. Wilson et
al22 showed that mechanical
strain increased DNA synthesis in vascular smooth muscle cells on
collagen, fibronectin, or vitronectin but not on cells on
elastin or laminin. Antibodies to both ß3 and
vß5 integrins, but not antibodies to
ß1 integrins, inhibited strain-induced DNA
synthesis. Furthermore, they found that RGD peptide blocked the
strain-induced mitogenic response and expression and
secretion of PDGF. Other studies demonstrated that, in neonatal rat
vascular smooth muscle cells, strain-induced activation of ERK MAP
kinases, expression of smooth muscle myosin, and expression of the
immediate early genes Egr-1 and c-jun were dependent on the composition
of the plating
medium.11 17
These studies indicate that it is not indiscriminate stretch of the
cells that initiates a response but rather that adhesion molecules are
acting as specific receptors that determine the nature of the response.
Which focal adhesion sites are formed and capable of participating in
the signaling pathway depends on the surrounding matrix. In the
present study we used the isolated small artery preparation to
ensure physiologically relevant cell-cell and
cell-matrix interactions.
The current results show that 3 different src family tyrosine kinase inhibitors, herbimycin A, PP1, and PP2, all suppressed the pressure-induced rise in c-fos expression. Because PP1 and PP2 are highly specific for src tyrosine kinases,35 these findings suggest that activation of src is required for pressure-induced c-fos expression. Why baseline c-fos levels at 90 mm Hg were increased in the presence of PP2 is not clear. Hanke et al35 showed that PP1 and PP2 are closely related pyrazolopyrimidines, but, although they are both extremely potent and selective src inhibitors, their inhibitory action on the different src family kinases shows some degree of variation. Nevertheless, the finding that PP2 blocked the pressure-induced increase in gene expression is consistent with the effects of the other src inhibitors.
The ERK MAP kinase pathway has been associated with vascular remodeling in response to hypertension. In vivo experiments showed rapid activation of ERK in rat aorta in response to acute hypertension.23 Likewise, mechanical stimulation of large arteries in vitro or cultured vascular smooth muscle cells caused quick activation of ERK.12 13 25 26 Moreover, it is generally accepted that activation of ERK MAP kinases leads to proto-oncogene expression and eventually to a growth response.30 31 36 The present results show, for the first time, that high pressure rapidly phosphorylates ERK in intact small arteries. A 1-minute, as well as a 10-minute, exposure to high pressure did not uniformly change ERK phosphorylation, but a 5-minute exposure to 140 mm Hg consistently increased ERK phosphorylation in all 3 experiments (Figure 3A). This suggests that in intact small arteries ERK phosphorylation in response to high pressure may be biphasic in time, as was found by others in different experimental settings13 23 26 ; a 1-minute exposure may in some cases not be sufficient to start ERK phosphorylation, which appears to peak after 5 minutes, and after 10 minutes levels of ERK phosphorylation in some arteries may have returned to (or even below) baseline. The involvement of the ERK cascade in pressure-induced c-fos expression was tested by means of PD98059. For unknown reasons c-fos levels at 90 mm Hg were elevated compared with control at 90 mm Hg. One might speculate that other MAP kinases may have compensated for the inhibition of ERK, but obviously this needs to be tested. Nevertheless, in the presence of PD98059, high pressure did not increase c-fos expression. Thus, the results not only indicate that ERK is activated by pressure but also suggest that its activation is essential for the transmission of the pressure stimulus to gene expression. The finding that levels of ERK phosphorylation are hardly or not detectable in the presence of PP1 suggests that activation of src is required for both basal, pressure-independent, ERK phosphorylation and for the propagation of the pressure stimulus to subsequent ERK phosphorylation and c-fos expression. One could argue that PP1, even though it is supposed to be highly specific for src, blocked ERK phosphorylation directly. Although we cannot rule out this possibility, we are not aware of any evidence for such nonspecific PP1 activity. Therefore, we believe that these findings reflect the requirement of src activation for the propagation of the mitogenic transduction pathway. This view is consistent with results from earlier studies on other preparations. Davis et al9 showed that herbimycin A prevented the cyclic deformation-induced vascular smooth muscle growth. Birukov et al26 found that herbimycin A inhibited pressure-induced ERK activation in cannulated rabbit aorta in culture.
This kind of mechanotransduction appears not to be restricted to vascular smooth muscle cells. Similar mechanisms have been described for the transduction of fluid shear stress on vascular endothelial cells37 or the response of cardiac myocytes to mechanical stress.38 Combining the present observations with results from other studies, we propose the following model for the mechanotransduction of pressure to c-fos expression in rat mesenteric small arteries (Figure 4). High pressure increases wall stress, which may act on the integrins at the focal adhesion sites. This may activate src tyrosine kinases, which are linked to the ß-subunit of the integrins, allowing association with the adaptor protein complex Shc-Grb2-Sos. This would promote GTP binding on ras, phosphorylation, and activation of raf (MAPKKK), MEK (MAPKK), and ERK (MAPK). ERK may finally stimulate c-fos expression through phosphorylation of the TCF transcription factor (Figure 4).
|
It is, however, quite likely that the possible scenario depicted in Figure 4 is incomplete. We do not exclude other factors that are activated by mechanical stimulation and may act in concert with the aforementioned reaction cascade. In cultured vascular smooth muscle cells, it was found that mechanical stress induced phosphorylation of the PDGF and the epidermal growth factor receptor. Hu et al39 showed that antibodies to PDGF did not block this response, suggesting that mechanical stimulation may directly activate the PDGF receptor. Activation of the receptor leads to autophosphorylation of tyrosine residues within the receptor and downstream activation of src, Shc, Grb2, Sos, and ERK.36 In a recent report, Iwasaki et al14 described a similar mechanism for the epidermal growth factor receptor. Waltenberger and coworkers40 showed that PP1, apart from its src-inhibitory action, directly blocked PDGF receptor tyrosine kinase activity. Thus, we cannot exclude that the PP1 effects in the present study were caused by blockade of the PDGF receptor rather than src inhibition.
In summary, we confirmed the previously found pressure-induced increase in c-fos expression in intact cannulated rat mesenteric small arteries. Specific inhibition of src tyrosine kinases and the ERK MAP kinase cascade blocked this effect of pressure. In addition, elevated pressure increased ERK phosphorylation, which was inhibited by PP1. These results suggest that activation of src tyrosine kinases and the ERK pathway may mediate pressure-induced c-fos expression in intact rat mesenteric small arteries.
| Acknowledgments |
|---|
Received April 18, 2000; first decision May 18, 2000; accepted August 31, 2000.
| References |
|---|
|
|
|---|
2.
Baumbach GL,
Heistad DD. Remodeling of cerebral arterioles in chronic hypertension.
Hypertension. 1989;13:968972.
3.
Rizzoni D, Porteri
E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, Giulini SM,
Agabiti-Rosei E. Vascular hypertrophy and remodeling in
secondary hypertension.
Hypertension. 1996;28:785790.
4.
Struijker-Boudier
HAJ, van Essen H, Fazzi G, De Mey JGR, Qiu HY, Levy BI. Disproportional
arterial hypertrophy in hypertensive mRen-2
transgenic rats. Hypertension. 1996;28:779784.
5.
Heagerty AM,
Aalkjær C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in
hypertension: dual processes of remodeling and growth.
Hypertension. 1993;21:391397.
6. Mulvany MJ, Baumbach GL, Aalkjær C, Heagerty AM, Korsgaard N, Schiffrin EL, Heistad DD. Vascular remodeling. Hypertension. 1996;28:505506.
7.
Bund SJ, West KP,
Heagerty AM. Effects of protection from pressure on resistance artery
morphology and reactivity in spontaneously hypertensive and
Wistar-Kyoto rats. Circ Res. 1991;68:12301240.
8.
Parker SB, Wade SS,
Prewitt RL. Pressure mediates angiotensin IIinduced
arterial hypertrophy and PDGF-A expression.
Hypertension. 1998;32:452458.
9.
Davis MG, Ali S,
Leikauf GD, Dorn GW. Tyrosine kinase inhibition prevents
deformation-stimulated vascular smooth muscle growth.
Hypertension. 1994;24:706713.
10.
Wilson E, Mai Q,
Sudhir K, Weiss RH, Ives HE. Mechanical strain induces growth of
vascular smooth muscle cells via autocrine action of PDGF.
J Cell Biol. 1993;123:741747.
11. Reusch HP, Chan G, Ives HE, Nemenoff RA. Activation of JNK/SAPK and ERK by mechanical strain in vascular smooth muscle cells depends on extracellular matrix composition. Biochem Biophys Res Commun. 1997;237:239244.[Medline] [Order article via Infotrieve]
12.
Hamada K, Takuwa
N, Yokoyama K, Takuwa Y. Stretch activates Jun N-terminal
kinase/stress-activated protein kinase in vascular smooth
muscle cells through mechanisms involving autocrine ATP stimulation of
purinoceptors. J Biol
Chem. 1998;273:63346340.
13.
Li C, Hu Y, Mayr
M, Xu Q. Cyclic strain stress-induced mitogen-activated protein
kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells
is regulated by Ras/Rac-MAPK pathways.
J Biol Chem. 1999;274:2527325280.
14. Iwasaki H, Eguchi S, Ueno H, Marumo F, Hirata Y. Mechanical stretch stimulates growth of vascular smooth muscle cells via epidermal growth factor receptor. Am J Physiol. 2000;278:H521H529.
15. Bhalla RC, Sharma RV. Induction of c-fos and elastin gene in response to mechanical stretch of vascular smooth muscle cells. J Vasc Med Biol. 1993;4:130137.
16.
Cowan DB, Lye SJ,
Langille BL. Regulation of vascular connexin43 gene expression by
mechanical loads. Circ Res. 1998;82:786793.
17.
Morawietz H, Ma
Y, Vives F, Wilson E, Sukhatme VP, Holtz J, Ives HE. Rapid induction
and translocation of Egr-1 in response to mechanical strain in vascular
smooth muscle cells. Circ Res. 1999;84:678687.
18. Standley PR, Obards TJ, Martina CL. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: implications in vascular hyperplasia. Am J Physiol. 1999;276:E697E705.
19.
Cheng GC, Briggs
WH, Gerson DS, Libby P, Grodzinsky AJ, Gray ML, Lee RT. Mechanical
strain tightly controls fibroblast growth factor-2 release from
cultured human vascular smooth muscle cells.
Circ Res. 1997;80:2836.
20.
Reusch P, Wagdy
H, Reusch R, Wilson E, Ives HE. Mechanical strain increases smooth
muscle and decreases nonmuscle myosin expression in rat vascular smooth
muscle cells. Circ Res. 1996;79:10461053.
21.
Sumpio BE, Banes
AJ, Link WG, Johnson G. Enhanced collagen production by smooth
muscle cells during repetitive mechanical stretching.
Arch Surg. 1988;123:12331236.
22. Wilson E, Sudhir K, Ives HE. Mechanical strain of rat vascular smooth muscle cells is sensed by specific extracellular matrix/integrin interactions. J Clin Invest. 1995;96:23642372.
23. Xu Q, Liu Y, Gorospe M, Udelsman R, Holbrook NJ. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest. 1996;97:508514.[Medline] [Order article via Infotrieve]
24. Dobrian A, Wade SS, Prewitt RL. PDGF-A expression correlates with blood pressure and remodeling in 1K1C hypertensive rat arteries. Am J Physiol. 1999;276:H2159H2167.
25.
Adam LP, Franklin
MT, Raff GJ, Hathaway DR. Activation of mitogen-activated
protein kinase in porcine carotid arteries.
Circ Res. 1995;76:183190.
26.
Birukov KG,
Lehoux S, Birukova AA, Merval R, Tkachuk VA, Tedgui A. Increased
pressure induces sustained protein kinase Cindependent herbimycin
Asensitive activation of extracellular signalrelated kinase 1/2 in
the rabbit aorta in organ culture. Circ
Res. 1997;81:895903.
27.
Allen SP, Liang
HM, Hill MA, Prewitt RL. Elevated pressure stimulates protooncogene
expression in isolated mesenteric arteries.
Am J Physiol. 1996;271:H1517H1523.
28.
Allen SP, Wade
SS, Prewitt RL. Myogenic tone attenuates pressure-induced gene
expression in isolated small arteries.
Hypertension. 1997;30:203208.
29.
Miriel VA, Allen
SP, Schriver SD, Prewitt RL. Genistein inhibits pressure-induced
expression of c-fos in isolated mesenteric arteries.
Hypertension. 1999;34:132137.
30. Williams B. Mechanical influences on vascular smooth muscle cell function. J Hypertens. 1998;16:19211929.[Medline] [Order article via Infotrieve]
31.
Lehoux S, Tedgui
A. Signal transduction of mechanical stresses in the vascular wall.
Hypertension. 1998;32:338345.
32.
Fenger-Gron J,
Mulvany MJ, Christensen KL. Mesenteric blood pressure profile of
conscious, freely moving rats. J
Physiol. 1995;488:753760.
33.
Clements ML,
Banes AJ, Faber JE. Effect of mechanical loading on vascular
1D- and
1B-adrenergic receptor expression.
Hypertension. 1997;29:11561164.
34.
Sun D, Messina
EJ, Kaley G, Koller A. Characteristics and origin of myogenic response
in isolated mesenteric arterioles. Am
J Physiol. 1992;263:H1486H1491.
35.
Hanke JH, Gardner
JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA,
Connelly PA. Discovery of a novel, potent, and Src family-selective
tyrosine kinase inhibitor.
J Biol Chem. 1996;271:695701.
36.
Force T,
Bonventre JV. Growth factors and mitogen-activated protein
kinases. Hypertension. 1998;31:152161.
37.
Chien S, Li S,
Shyy JY. Effects of mechanical forces on signal transduction and gene
expression in endothelial cells.
Hypertension. 1998;31:162169.
38. Sadoshima J, Izumo S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol. 1997;59:551571.[Medline] [Order article via Infotrieve]
39.
Hu Y, Böck G,
Wick G, Xu Q. Activation of PDGF receptor
in vascular smooth muscle
cells by mechanical stress. Faseb
J. 1998;12:11351142.
40.
Waltenberger J,
Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A,
Hombach V, Levitzki A, Böhmer F. A dual inhibitor of
platelet-derived growth factor ß-receptor and src kinase activity
potently interferes with motogenic and mitogenic responses
to PDGF in vascular smooth muscle cells: a novel candidate for
prevention of vascular remodeling. Circ
Res. 1999;85:1222.
This article has been cited by other articles:
![]() |
T. M. Paravicini and R. M. Touyz Redox signaling in hypertension Cardiovasc Res, July 15, 2006; 71(2): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. R. De Mey, P. M. Schiffers, R. H. P. Hilgers, and M. M. W. Sanders Toward functional genomics of flow-induced outward remodeling of resistance arteries Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1022 - H1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Spurrell, T. V. Murphy, and M. A. Hill Intraluminal pressure stimulates MAPK phosphorylation in arterioles: temporal dissociation from myogenic contractile response Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1764 - H1773. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Hill, S. J. Potocnik, L. A. Martinez-Lemus, and G. A. Meininger Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H849 - H856. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. E.G. Eskildsen-Helmond and M. J. Mulvany Pressure-Induced Activation of Extracellular Signal-Regulated Kinase 1/2 in Small Arteries Hypertension, April 1, 2003; 41(4): 891 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Massett, Z. Ungvari, A. Csiszar, G. Kaley, and A. Koller Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2282 - H2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mulvany Small Artery Remodeling and Significance in the Development of Hypertension Physiology, June 1, 2002; 17(3): 105 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Rice, A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Src Autophosphorylation is an Early Event in Pressure-Mediated Signaling Pathways in Isolated Resistance Arteries Hypertension, February 1, 2002; 39(2): 502 - 507. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |